Tenderwize
Retour à la recherche

Open House Original Discount Contracts 2025-17 - Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09)

Techniker Krankenkasse·Hamburg, Germany·Deadline Jun 29, 2027 · 307 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-17 - Beclometason, Formoterol, Glycopyrronium (Wirkstoffkombination) ATC: R03AL09

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

30 / 100

Facteurs de risque

No estimated contract value provided; potential revenue cannot be assessed.

Contract terminates automatically upon patent expiry or loss of market exclusivity, which could shorten contract durati...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Supply of pharmaceutical products containing active ingredient combination Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09)
  • Nationwide delivery in Germany
Afficher le résumé complet

Open House procedure (non-procurement) by Techniker Krankenkasse and associated health insurers for discount contracts (Rabattverträge) for the active ingredient combination Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09). The contract is a supply of pharmaceutical products. No estimated value provided. Contract duration max 24 months from 01.07.2025 to 30.06.2027. Participation possible anytime during the contract period. Submission by email (with qualified electronic signature) or post. No exclusivity.

Risques

No estimated contract value provided; potential revenue cannot be assessed.

Contract terminates automatically upon patent expiry or loss of market exclusivity, which could shorten contract durati...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as per §4 Abs. 18 AMG
  • Must hold a valid marketing authorization for the specific drug combination or be entitled to market it

Eligibility

  • Must submit a self-declaration (Anlage 4) confirming eligibility and reliability

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria specified; all qualified participants are accepted.

Acheteur

Localisation

Hamburg, DEU

Identifiant

992-80116-93

Activité

Health

Lots (1)

LOT-0001

Open House Original Discount Contracts 2025-17 - Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09)

Discount contracts for the active ingredient combination Beclometason, Formoterol, Glycopyrronium (ATC: R03AL09) nationwide in Germany.

SuppliesEU fundedElectronic submission

Localisation

DE600, Germany

Durée

Jun 2025 - Jun 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria specified; all qualified participants are accepted.

Date limite

Deadline Jun 29, 2027

Détails de la procédure

Date de publication
22 May 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
332579-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3